Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons.

Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons.
复制标题

DOI:
10.2337/db17-1385
复制
发表时间:
2018-08
期刊:
影响因子:
7.7
通讯作者:
Olson DP
Olson DP
中科院分区:
医学1区
文献类型:
--
作者:
Adams JM;Pei H;Sandoval DA;Seeley RJ;Chang RB;Liberles SD;Olson DP

文献摘要

参考文献

被引文献

相似文献

胰高血糖素样肽1受体(GLP-1 R)激动剂是美国食品和药物管理局批准的减肥药物。尽管GLP-1 R激动剂(GLP 1 RA)被广泛使用,但其影响食欲和体重的作用部位仍不完全清楚。我们确定了GABA能或谷氨酸能神经元中的GLP-1 R是否是GLP 1 RA利拉鲁肽对摄食量、内脏疾病、体重和神经网络激活的短期和长期影响所必需的。我们发现,在表达vGAT的GABA能神经元中缺乏GLP-1 Rs的小鼠在所有测量参数中的反应与对照组相同,而在表达vGlut 2的GABA能神经元中缺失GLP-1 Rs消除了利拉鲁肽诱导的体重减轻和内脏疾病,并严重减弱了其对进食的影响。同时,从多巴胺能神经元中删除GLP-1 R完全消除了利拉鲁肽给药后观察到的神经网络激活。我们得出结论,利拉鲁肽激活分散但离散的神经网络以介导其生理效应,并且这些效应需要GLP-1 R在谷氨酸能神经元而非GABA能神经元上表达。
Glucagon-like peptide 1 receptor (GLP-1R) agonists are U.S. Food and Drug Administration–approved weight loss drugs. Despite their widespread use, the sites of action through which GLP-1R agonists (GLP1RAs) affect appetite and body weight are still not fully understood. We determined whether GLP-1Rs in either GABAergic or glutamatergic neurons are necessary for the short- and long-term effects of the GLP1RA liraglutide on food intake, visceral illness, body weight, and neural network activation. We found that mice lacking GLP-1Rs in vGAT-expressing GABAergic neurons responded identically to controls in all parameters measured, whereas deletion of GLP-1Rs in vGlut2-expressing glutamatergic neurons eliminated liraglutide-induced weight loss and visceral illness and severely attenuated its effects on feeding. Concomitantly, deletion of GLP-1Rs from glutamatergic neurons completely abolished the neural network activation observed after liraglutide administration. We conclude that liraglutide activates a dispersed but discrete neural network to mediate its physiological effects and that these effects require GLP-1R expression on glutamatergic but not GABAergic neurons.
DOI: 10.1523/jneurosci.3262-11.2011
发表时间: 2011-10-12
期刊: The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子: --
作者:
Dossat AM;Lilly N;Kay K;Williams DL
通讯作者: Williams DL
DOI: 10.1016/j.neuroscience.2011.02.023
发表时间: 2011-04-28
期刊: NEUROSCIENCE
影响因子: 3.3
作者:
Llewellyn-Smith, I. J.;Reimann, F.;Gribble, F. M.;Trapp, S.
通讯作者: Trapp, S.
下丘脑胰高血糖素样肽1受体足够,但对于调节小鼠的能量平衡和葡萄糖稳态不需要。
DOI: 10.2337/db16-1102
发表时间: 2017-02
期刊: Diabetes
影响因子: 7.7
作者:
Burmeister MA;Ayala JE;Smouse H;Landivar-Rocha A;Brown JD;Drucker DJ;Stoffers DA;Sandoval DA;Seeley RJ;Ayala JE
通讯作者: Ayala JE
DOI: 10.1152/ajpregu.00424.2010
发表时间: 2011-10-01
影响因子: 2.8
作者:
Baraboi, Elena-Dana;St-Pierre, David H.;Richard, Denis
通讯作者: Richard, Denis
DOI: 10.2337/db15-0973
发表时间: 2016-01-01
期刊: DIABETES
影响因子: 7.7
作者:
Krieger, Jean-Philippe;Arnold, Myrtha;Lee, Shin J.
通讯作者: Lee, Shin J.